SCHEMBL5673418

SCHEMBL5673418

Cc1ccc(-n2nc(C)c(N=Nc3cc(C(=O)O)ccc3O)c2O)cc1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.42
▸ MAPT P10636 2/20 0.42
▸ CYP1A2 P05177 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ METTL3 Q86U44 2/20 0.40
▸ METTL14 Q9HCE5 2/20 0.40
▸ MPL P40238 2/20 0.40
▸ SLCO2B1 O94956 1/20 0.40
▸ KCNH2 Q12809 1/20 0.40
▸ SLCO1B3 Q9NPD5 1/20 0.40
▸ ABCG2 Q9UNQ0 1/20 0.40
▸ SLCO1B1 Q9Y6L6 1/20 0.40
▸ ALDH1A1 P00352 3/20 0.38
▸ STAT1 P42224 1/20 0.38
▸ HTT P42858 2/20 0.38
▸ NPC1 O15118 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ PAX8 Q06710 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5673412 1.00 LMNA (0.42) LMNAMAPTCYP1A2CYP2C19NPSR1
SCHEMBL5672419 0.91 LMNA (0.42) LMNAMAPTCYP1A2CYP2C19NPSR1
SCHEMBL5672426 0.91 LMNA (0.42) LMNAMAPTCYP1A2CYP2C19NPSR1
SCHEMBL5675194 0.81 MPL (0.42) LMNAMAPTCYP1A2CYP2C19METTL3
SCHEMBL5675193 0.81 MPL (0.42) LMNAMAPTCYP1A2CYP2C19METTL3
SCHEMBL5673468 0.80 ALDH1A1 (0.43) LMNAMAPTNPSR1ALDH1A1HTT
SCHEMBL5673471 0.80 ALDH1A1 (0.43) LMNAMAPTNPSR1ALDH1A1HTT
SCHEMBL5673425 0.80 MPL (0.44) LMNAMAPTCYP1A2CYP2C19NPSR1
SCHEMBL5673730 0.80 MPL (0.44) LMNAMAPTCYP1A2CYP2C19NPSR1
SCHEMBL5673351 0.79 LMNA (0.39) LMNAMAPTCYP1A2CYP2C19NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1213965-B1 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORP (US) 2006-01-18 — — EP claimed
US-6642265-B1 Treating thrombocytopenia, in a mammal, including a human, by administering a hydroxy-1-azobenzene derivative SMITHKLINE BEECHAM CORPORATION 2003-11-04 — — US claimed
EP-1213965-B1 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORP (US) 2006-01-18 — — EP disclosed
US-6642265-B1 Treating thrombocytopenia, in a mammal, including a human, by administering a hydroxy-1-azobenzene derivative SMITHKLINE BEECHAM CORPORATION 2003-11-04 — — US disclosed
EP-1213965-A4 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORP (US) 2003-05-02 — — EP disclosed
EP-1213965-A1 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORPORATION (US) 2002-06-19 — — EP disclosed
WO-2001017349-A1 THROMBOPOIETIN MIMETICS SMITHKLINE BECKMAN CORPORATION (US) 2001-03-15 — — WO disclosed
Send feedback